Amylyx reports strong Phase 2b trial data for avexitide, showing 64% fewer hypoglycemic events in patients with ...

The study included 12 patients who suffer from a subset of Type 1 diabetes known as hypoglycemic unawareness, characterized ...

When you think about who is likely to be impacted by low blood sugar, you may think of someone living with diabetes. Although ...

Injecting glucagon thus helps the diabetic person's blood sugar return to a healthy level when their body is unable to take ...

Hypoglycemia – a condition in which low blood glucose levels can cause you to feel dizzy, weak, and shaky – can catch you by ...

Hypoglycemia occurs when a person's blood sugar levels drop too low. It can cause dizziness, confusion, and loss of consciousness, among other symptoms. While diabetes is the most common cause of ...

MIT engineers have developed a tiny implantable device that could revolutionize emergency treatment for people with Type 1 ...

A large-scale Mendelian randomization study found no genetic evidence that vitamins A, C, or D reduce the risk of major ...

For individuals with type 1 diabetes – an autoimmune condition – maintaining stable blood sugar is a constant challenge.

MIT’s wireless skin implant delivers glucagon instantly when blood sugar drops, offering new safety for diabetics, even while ...

MIT engineers have designed an implantable reservoir that can remain under the skin and be triggered to release glucagon when ...

MIT researchers have developed an implant that releases glucagol under the control of external sensors to protect diabetes ...